stockportfolio.pro
Stocks / LMAT vs SEM
LMAT vs SEM
LeMaitre Vascular, Inc. and Select Medical Holdings Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| LeMaitre Vascular, Inc. (LMAT) | Select Medical Holdings Corporation (SEM) | |
|---|---|---|
| Market cap | $2.1B | $2.1B |
| Revenue (latest FY) | $249.60M | $5.45B |
| Net income (latest FY) | $57.73M | $146.22M |
| Revenue growth (5y CAGR) | 14.0% | -0.3% |
| Net margin | 23.1% | 2.7% |
| Return on equity | 14.7% | 8.6% |
| P/E ratio | 34.1 | 15.5 |
| Dividend yield | 1.0% | 1.5% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open LMAT — free Open SEM — freeFrequently asked questions
Which is bigger, LMAT or SEM?
LeMaitre Vascular, Inc. is larger by market capitalization — $2.1B versus $2.1B.
Which grows faster, LMAT or SEM?
Over the last five fiscal years, LeMaitre Vascular, Inc. grew revenue faster — 14.0%/yr versus -0.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.